 MELVILLE, N.Y., May 03, 2021 GLOBE NEWSWIRE -- BioRestorative Therapies, Inc. the Company or BioRestorative OTC: BRTX, a life sciences company focused on stem cell-based therapies, today announced that it has filed its Annual Report on Form 10-K for the year ended December 31, 2020 and, as a result, is now current in its SEC periodic filings. The filing of the Form 10-K has resulted in the removal of the stop sign from the OTC Markets website with regard to the Company, indicating that BioRestorative now has current public information available. 